• A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus 

      Cozen, W; Timofeeva, MN; Li, D; Diepstra, A; Hazelett, D; Delahaye-Sourdeix, Manon; Edlund, C; Franke, L; rostgaard, k; Van Den Berg, D; Cortessis, Victoria K.; Smedby, KE; Glaser, S; Westra, H-J; Robison, L; Mack, T; Hwang, A; Nieters, A; de Sanjose, S; Lightfoot, T; Becker, N; Maynadie, M; Foretova, L; Roman, E; Benavente, Y; Rand, KA; Nathwani, Bharat; Glimelius, B; Staines, A; Boffetta, P; Link, B; Kiemeney, L; Ansell, S; Bhatia, Sonal; Strong, L; Galan, P; Vatten, Lars Johan; Habermann, T; Duell, E J; Lake, A; Veenstra, René; Visser, L; Liu, Y; Urayama, KY; Montgomery, D; Gaborieau, V; Weiss, L; Byrnes, G; Lathrop, M; Cocco, P; Best, Thomas M.; Skol, A; Adami, H-O; Melbye, M; Cerhan, JR; Gallagher, Alison M.; Taylor, G; Slager, S; Coetzee, GA; Brennan, P; Conti, David; Onel, K; Hjalgrim, H; Jarrett, RF; Van Den Berg, A; McKay, JD (Journal article; Peer reviewed, 2014)
      Recent genome-wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. ...
    • Icotinib is an active treatment of non-small-cell lung cancer: A retrospective study 

      Chen, X; Zhu, Q; Liu, Y; Liu, P; Yin, Y; Guo, R; Lu, K; Gu, Y; Liu, L; Wang, J; Wang, Z; Røe, Oluf Dimitri; Shu, Y; Zhu, L (Journal article; Peer reviewed, 2014)
      Background Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung cancer (NSCLC). This retrospective ...